Company / SG&A per Share
Biofrontera Inc. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.81
FY2025
5-year range
$2.21 / $42.69
FY2021-FY2025
Trend
-68.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 3 consecutive years, from $42.69 in FY2022 to $3.81 in FY2025.
Based on SEC 10-K filings.
3.81 in FY2025 with a 3-year CAGR of -55.3%.
Improved from $26.32 to $3.81 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -55.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Biofrontera Inc.'s sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 68.7% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.81 | -68.7% |
| FY2024 | $12.18 | -53.7% |
| FY2023 | $26.32 | -38.3% |
| FY2022 | $42.69 | +1828.9% |
| FY2021 | $2.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026